Bristol Myers on Wednesday said the European Commission approved the subcutaneous formulation of Opdivo for use across multiple adult solid tumors as monotherapy, monotherapy maintenance following ...

An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.